Assessment of optimum duration of therapy with oral dichloromethylene diphosphonate (clodronate) in the treatment of Paget's disease.
Khan
S
S
Department of Human Metabolism and Clinical Biochemistry, WHO Collaborating Centre for Metabolic Bone Disease, University of Sheffield Medical School, England.
McCloskey
E V
EV
Eyres
K S
KS
Fern
E D
ED
Kanis
J A
JA
D000284:Administration, Oral; D004002:Clodronic Acid / Q000008:administration & dosage*; D004334:Drug Administration Schedule; D006801:Humans; D010001:Osteitis Deformans / Q000188:drug therapy*; D012074:Remission Induction; D012189:Retrospective Studies
D004002:Clodronic Acid